PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells

Experimental Hematology

Volumn 40, Issue 12, 2012, Pages

  Kokorina, Natalia A ^a   Granier, Celine J ^b   Zakharkin, Stanislav O ^c   Davis, Stephani ^a   Rabson, Arnold B ^b,d   Sabaawy, Hatem E ^a,d  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^c Kraft Inc   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL PROTEIN; CYTARABINE; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN GAMMA CHAIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROGRAMMED CELL DEATH 2 PROTEIN; PROTEIN C MYB; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ARTICLE; BURST FORMING UNIT E; CD34 SELECTION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EPOR GENE; ERYTHROID PRECURSOR CELL; G3PDH GENE; GATA1 GENE; GATA2 GENE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; MEGAKARYOBLAST; MEGAKARYOCYTE ERYTHROID PROGENITOR; NORMAL HUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GENE;

EID: 84868688303     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.08.004     Document Type: Article

References (50)

1. Medvinsky A., Rybtsov S., Taoudi S. Embryonic origin of the adult hematopoietic system: advances and questions. Development 2011, 138:1017-1031.
2. Eaves C.J., Humphries R.K., Eaves A.C. In Vitro Characterization of Erythroid Precursor Cells and the Erythroid Differentiation Process 1982, Grune & Stratton, New York, 251-278.
3. Gordon M.Y. Human haemopoietic stem cell assays. Blood Rev 1993, 7:190-197.
4. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
5. Minakhina S., Steward R. Hematopoietic stem cells in Drosophila. Development 2010, 137:27-31.
6. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., Melton D.A. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002, 298:597-600.
7. Skottman H., Mikkola M., Lundin K., et al. Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 2005, 23:1343-1356.
8. Mu W., Munroe R.J., Barker A.K., Schimenti J.C. PDCD2 is essential for inner cell mass development and embryonic stem cell maintenance. Dev Biol 2010, 347:279-288.
9. Scarr R.B., Sharp P.A. PDCD2 is a negative regulator of HCF-1 (C1). Oncogene 2002, 21:5245-5254.
10. Tyagi S., Chabes A.L., Wysocka J., Herr W. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol Cell 2007, 27:107-119.
11. Kawakami T., Furukawa Y., Sudo K., et al. Isolation and mapping of a human gene (PDCD2) that is highly homologous to Rp8, a rat gene associated with programmed cell death. Cytogenet Cell Genet 1995, 71:41-43.
12. Merup M., Moreno T.C., Heyman M., et al. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood 1998, 91:3397-3400.
13. Steinemann D., Gesk S., Zhang Y., et al. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms. Genes Chromosomes Cancer 2003, 37:421-426.
14. Lozzio B.B., Lozzio C.B., Bamberger E.G., Feliu A.S. A multipotential leukemia cell line (K-562) of human origin. Proc Soc Exp Biol Med 1981, 166:546-550.
15. Wanda P.E., Walker M.M. Hemoglobin induction by Ara-C in human erythroleukemic cells (K562) is cell-cycle dependent. Leuk Res 1989, 13:683-688.
16. Rubin C.I., French D.L., Atweh G.F. Stathmin expression and megakaryocyte differentiation: a potential role in polyploidy. Exp Hematol 2003, 31:389-397.
17. Millington M., Arndt A., Boyd M., Applegate T., Shen S. Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells. PLoS One 2009, 4:e6461.
18. Gregory C.J., Eaves A.C. Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses. Blood 1977, 49:855-864.
19. Eaves C.J., Eaves A.C. Erythroid progenitor cell numbers in human marrow-implications for regulation. Exp Hematol 1979, 7(suppl 5):54-64.
20. Rowley P.T., Ohlsson-Wilhelm B.M., Farley B.A. K562 human erythroleukemia cells demonstrate commitment. Blood 1985, 65:862-868.
21. Strobe W. Wright-Giemsa and nonspecific esterase staining of cells. Current Protocols in Immunology 1997, John Wiley & Sons, Inc., Hoboken, NJ, A.3C.1-A.3C.3. J. Coligan (Ed.).
22. Delgado M.D., Quincoces A.F., Gomez-Casares M.T., et al. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells. Cancer Res 1992, 52:5979-5984.
23. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975, 45:321-334.
24. Klein E., Ben-Bassat H., Neumann H., et al. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 1976, 18:421-431.
25. Croce C.M., Huebner K., Isobe M., et al. Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints. Proc Natl Acad Sci U S A 1987, 84:7174-7178.
26. Leary J.F., Ohlsson-Wilhelm B.M., Giuliano R., LaBella S., Farley B., Rowley P.T. Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk Res 1987, 11:807-815.
27. Benz E.J., Murnane M.J., Tonkonow B.L., et al. Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci U S A 1980, 77:3509-3513.
28. Rowley P.T., Ohlsson-Wilhelm B.M. Demonstration of commitment by K562 human erythroleukemia cells. Prog Clin Biol Res 1985, 191:217-231.
29. Alitalo R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leuk Res 1990, 14:501-514.
30. Rosson D., O'Brien T.G. Constitutive c-myb expression in K562 cells inhibits induced erythroid differentiation but not tetradecanoyl phorbol acetate-induced megakaryocytic differentiation. Mol Cell Biol 1995, 15:772-779.
31. Lieu Y.K., Reddy E.P. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci U S A 2009, 106:21689-21694.
32. Tsiftsoglou A.S., Vizirianakis I.S., Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 2009, 61:800-830.
33. Chiba S., Takahashi T., Takeshita K., et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood 1997, 90:97-104.
34. Nakamura Y., Nakauchi H. A truncated erythropoietin receptor and cell death: a reanalysis. Science 1994, 264:588-589.
35. Rath A.V., Schmahl G.E., Niemeyer C.M. Expression of transcription factors during sodium phenylacetate induced erythroid differentiation in K562 cells. Blood Cells Mol Dis 1997, 23:27-38.
36. Kramer J., Granier C.J., Davis S., et al. PDCD2 controls hematopoietic stem cell differentiation during development. Stem Cells Dev 2012 Aug 16, [Epub ahead of print].
37. England S.J., McGrath K.E., Frame J.M., Palis J. Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 2011, 117:2708-2717.
38. Orford K.W., Scadden D.T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 2008, 9:115-128.
39. Takagaki K., Katsuma S., Kaminishi Y., et al. Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells. Genes Cells 2005, 10:97-106.
40. Minakhina S., Druzhinina M., Steward R. Zfrp8, the Drosophila ortholog of PDCD2, functions in lymph gland development and controls cell proliferation. Development 2007, 134:2387-2396.
41. Baron B.W., Anastasi J., Thirman M.J., et al. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A 2002, 99:2860-2865.
42. Baron B.W., Zeleznik-Le N., Baron M.J., et al. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proc Natl Acad Sci U S A 2007, 104:7449-7454.
43. Baron B.W., Hyjek E., Gladstone B., Thirman M.J., Baron J.M. PDCD2, a protein whose expression is repressed by BCL6, induces apoptosis in human cells by activation of the caspase cascade. Blood Cells Mol Dis 2010, 45:169-175.
44. Asari S., Sakamoto A., Okada S., et al. Abnormal erythroid differentiation in neonatal bcl-6-deficient mice. Exp Hematol 2005, 33:26-34.
45. Greig K.T., Carotta S., Nutt S.L. Critical roles for c-Myb in hematopoietic progenitor cells. Semin Immunol 2008, 20:247-256.
46. Mukai H.Y., Motohashi H., Ohneda O., Suzuki N., Nagano M., Yamamoto M. Transgene insertion in proximity to the c-myb gene disrupts erythroid-megakaryocytic lineage bifurcation. Mol Cell Biol 2006, 26:7953-7965.
47. Sandberg M.L., Sutton S.E., Pletcher M.T., et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 2005, 8:153-166.
48. Wessely O., Deiner E.M., Beug H., von Lindern M. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J 1997, 16:267-280.
49. Clarke M.F., Kukowska-Latallo J.F., Westin E., Smith M., Prochownik E.V. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 1988, 8:884-892.
50. Ezoe S., Matsumura I., Satoh Y., Tanaka H., Kanakura Y. Cell cycle regulation in hematopoietic stem/progenitor cells. Cell Cycle 2004, 3:314-318.